A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma-Reference-Cited by-同舟云学术

A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma

Published:2021-01-01 Issue:1 Volume:10 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Budczies Jan¹²,Kirchner Martina¹,Kluck Klaus¹²,Kazdal Daniel¹³,Glade Julia¹,Allgäuer Michael¹,Kriegsmann Mark¹³,Heußel Claus-Peter³⁴⁵,Herth Felix J.³⁶,Winter Hauke³⁷,Meister Michael³⁸,Muley Thomas³⁸,Fröhling Stefan²⁹,Peters Solange¹⁰,Seliger Barbara¹¹^ORCID,Schirmacher Peter¹²,Thomas Michael⁷¹²,Christopoulos Petros⁷¹²,Stenzinger Albrecht¹³

Affiliation:

1. Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany

2. German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany

3. Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, Germany

4. Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik at Heidelberg University Hospital, Heidelberg, Germany

5. Department of Diagnostic and Interventional Radiology, Heidelberg University Hospital, Heidelberg, Germany

6. Department of Pneumology, Thoraxklinik at Heidelberg University Hospital, Heidelberg, Germany

7. Department of Thoracic Surgery, Thoraxklinik at Heidelberg University Hospital, Heidelberg, Germany

8. Translational Research Unit, Thoraxklinik at Heidelberg University Hospital, Heidelberg, Germany

9. Department of Translational Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany

10. Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne University, Lausanne, Switzerland

11. Institute for Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany

12. Department of Thoracic Oncology, Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany

Funder

the German Center for Lung Research

German Cancer Consortium

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1860586

Reference48 articles.

1. Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

2. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

3. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

4. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

5. Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure)

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in tumor-infiltrating lymphocytes: Historical insights, contemporary milestones, and future directions in oncology therapy;Critical Reviews in Oncology/Hematology;2024-10

2. Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy;Expert Review of Clinical Immunology;2024-07-16

3. CRTAC1 identified as a promising diagnosis and prognostic biomarker in lung adenocarcinoma;Scientific Reports;2024-05-16

4. Unravelling the puzzle of immunotherapeutic efficacy in lung cancer;Translational Lung Cancer Research;2024-05

5. Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application;Molecular Cancer;2024-04-06